Form D · Pharmaceuticals
OurPharma Holdings LLC
Fayetteville, AR · CIK 0001725565
Offering snapshot reported Jul 10, 2026 · SEC filing
- Reported sold
- $500K Offering amount: $3.45M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jul 21, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$250,000 → $500,000
- Reported investors1 → 3
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2026 | Amendment | $500,000 | $250,000vs Jul 23, 2025 | 3 | SEC filing |
| Jul 23, 2025 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Feb 20, 2024 | Amendment | $13,450,000 | $3,000,000vs Feb 24, 2023 | 30 | SEC filing |
| Feb 24, 2023 | Amendment | $10,450,000 | $500,000vs Mar 10, 2022 | 19 | SEC filing |
| Mar 10, 2022 | Amendment | $9,950,000 | $4,450,000vs Oct 7, 2021 | 24 | SEC filing |
| Oct 7, 2021 | Amendment | $5,500,000 | $2,000,000vs Dec 10, 2020 | 13 | SEC filing |
| Dec 10, 2020 | Amendment | $3,500,000 | $1,600,000vs Aug 14, 2019 | 10 | SEC filing |
| Aug 14, 2019 | Initial | $1,900,000 | No comparison | 6 | SEC filing |
| Dec 21, 2017 | Initial | $2,225,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-552600
Source: Form D, filed Jul 10, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brent Beaulieu | Director |
| Brooke Culp | Director |
| Brooke Erwin | Director |
| Peter Kohler | Director, Executive |
| Todd Kohler | Director |
| Adam Kohler | Director, Executive |
| Stephen Kohler | Director |
| Michael Mauldin | Director |
| Ramona Mc Lean | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Fayetteville, AR, 72701
Phone: 479-871-7341